| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/11/2013 | US20130178427 Mu opioid receptor agonist analogs of the endomorphins |
| 07/11/2013 | US20130178412 Dihydroxyproply-cysteine peptide and agent containing this peptide |
| 07/11/2013 | US20130177567 Novel c3c epitope, antibodies binding thereto, and use thereof |
| 07/11/2013 | DE102008047781B4 Peptide, die an durch Matrix-Metalloprotease 2 modifiziertes humanes Kollagen IV binden, pharmazeutische Zubereitung und deren Verwendung Peptides that bind to modified by matrix metalloprotease 2 human collagen IV, pharmaceutical preparation and the use thereof |
| 07/10/2013 | EP2611823A1 Peptide containing multiple n-linked glycosylation sequons |
| 07/10/2013 | EP2611822A2 Compositions for labeling nerves and methods of use |
| 07/10/2013 | EP2261376B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 07/10/2013 | CN103201282A Dermatopontin-activating peptides and cosmetic compositions including same |
| 07/10/2013 | CN103200951A Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition |
| 07/10/2013 | CN103200950A Novel auristatin derivatives and use thereof |
| 07/10/2013 | CN103194519A Method for preparing antioxidative peptide through proteolysis on pea protein and application thereof |
| 07/10/2013 | CN103193868A Purification method of echinocandins antifungal drug anidulafungin |
| 07/10/2013 | CN103193867A 18F-RGD polypeptide and application thereof as PET imaging agent |
| 07/10/2013 | CN103193866A Odorranawuchuanensis antioxidant peptide wuchuanin-B2 and gene and application of coding sequence thereof |
| 07/10/2013 | CN103193865A Sendai virus antigen peptide and application thereof in Sendai virus infection detection |
| 07/10/2013 | CN102827252B One kind of magnetic resonance imaging developers and two-photon imaging developers and preparation method thereof |
| 07/10/2013 | CN102516366B Th1 cell factor immunoregulation polypeptide and application thereof |
| 07/10/2013 | CN102516363B CTL (Cytotoxic T Lymphocytes) epitope peptide from PL2L60 source and application thereof |
| 07/10/2013 | CN102382177B Method for extracting, separating and purifying enramycin |
| 07/10/2013 | CN102329376B Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof |
| 07/10/2013 | CN102329374B Gastric-cancer targeted peptide and application thereof |
| 07/10/2013 | CN102295685B 18F-labeled PRGD2 compound, kit thereof, preparation method of kit thereof, and application thereof |
| 07/10/2013 | CN102212116B Acetylcholine receptor mediated brain-targeted polypeptide and application thereof |
| 07/10/2013 | CN102203118B Peptide antagonist of interleukin-15 activity |
| 07/10/2013 | CN101570570B Synthetic method for somatostatin |
| 07/09/2013 | US8481679 Immobilizing an entity in a desired orientation on a support material |
| 07/09/2013 | US8481678 Peptide-based tooth whitening reagents |
| 07/09/2013 | US8481494 Compounds for the treatment of diseases related to protein misfolding |
| 07/09/2013 | US8481485 Insulin analogs |
| 07/09/2013 | US8481484 Cyclic heptapeptide and use of the same |
| 07/09/2013 | US8481332 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | CA2565678C Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 07/04/2013 | WO2013100721A1 Novel antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated four times, and use thereof |
| 07/04/2013 | WO2013067160A3 Anti-bacterial polypeptides and pathogen specific synthetic antibodies |
| 07/04/2013 | WO2013057736A3 Preparation of eptifibatide peptide |
| 07/04/2013 | WO2013036778A3 Compstatin analogs with improved pharmacokinetic properties |
| 07/04/2013 | US20130172530 Novel JNK Inhibitor Molecules |
| 07/04/2013 | US20130172276 Processes and intermediates |
| 07/04/2013 | US20130172272 Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof |
| 07/04/2013 | US20130172270 Rgd-containing cyclic peptides |
| 07/04/2013 | US20130172265 Methods and Compositions for Inhibiting Tumor Cell Proliferation |
| 07/04/2013 | US20130172258 Angiogenesis-inhibiting peptide and application thereof |
| 07/04/2013 | US20130172242 Growth hormone secretatogue receptor antagonists and uses thereof |
| 07/04/2013 | US20130172231 Composition for treating sepsis or septic shock comprising the peptide originated from the smad6 |
| 07/04/2013 | US20130172230 Treating Stroke and Other Diseases Without Inhibiting N-Type Calcium Channels |
| 07/04/2013 | US20130171178 Immunogenic Peptides of Xage-1 |
| 07/04/2013 | US20130171074 Targeting compounds |
| 07/04/2013 | US20130171069 Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof |
| 07/03/2013 | EP2610619A1 Hemokinin-1 receptor and hemokinin-1-derived peptide |
| 07/03/2013 | EP2142562B1 Stitched polypeptides |
| 07/03/2013 | CN103189510A TTLL4 peptides and vaccines containing the same |
| 07/03/2013 | CN103189068A Compositions for drug administration |
| 07/03/2013 | CN103189067A Inhibition of WDR5 interaction with its binding partners and therapeutic methods |
| 07/03/2013 | CN103183727A Preparation method of capreomycin |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183725A A method of detecting protein lysine crotonylation acylation modification and developing affinity reagents |
| 07/03/2013 | CN102532271B Brucella B cell epitope and monoclonal antibody and application thereof |
| 07/03/2013 | CN102432673B Brucella bp26 protein epitope, monoclonal antibody and application thereof |
| 07/03/2013 | CN102391360B Small peptide capable of resisting thrombosis and platelet aggregation |
| 07/03/2013 | CN102206249B Specific B cell epitope polypeptide of NS1 protein of encephalitis B virus and use thereof |
| 07/03/2013 | CN101935339B Solid-phase preparation method for buserelin |
| 07/03/2013 | CN101481406B H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/03/2013 | CN101357936B Method for synthesizing triptorelin from solid phase polypeptide |
| 07/02/2013 | US8476408 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 07/02/2013 | US8476407 Metallopeptide catalysts |
| 07/02/2013 | US8476306 Urokinase inhibitors, production and use thereof |
| 07/02/2013 | US8476040 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/02/2013 | US8475772 Peptide-based oral care surface reagents for personal care |
| 06/27/2013 | WO2013096939A1 Selective binding compounds |
| 06/27/2013 | WO2013096823A1 Cationic peptides and use of such peptides for inhibiting exotoxin production |
| 06/27/2013 | WO2013096697A2 Isolation, identification, and used of antifungal compounds |
| 06/27/2013 | WO2013094720A1 Composition having cell-adhesion-promoting activity |
| 06/27/2013 | WO2013094697A1 Anti-tumor peptide and use therefor |
| 06/27/2013 | WO2013093639A1 Process for the synthesis of therapeutic peptides |
| 06/27/2013 | WO2013092742A1 Method for patient selection |
| 06/27/2013 | WO2013092212A1 Peptidic inhibitor of signal transmission from g-alpha-s to g-alpha-i-coupled receptor cascades |
| 06/27/2013 | WO2013091883A2 Selective gpcr ligands |
| 06/27/2013 | WO2013091661A2 Proteolytic resistant protein affinity tag |
| 06/27/2013 | WO2013091361A1 Cycloheptapeptide and use thereof in preparation of anti-tumour drugs |
| 06/27/2013 | WO2013091070A1 Cyclic peptide mixtures from flaxseed and uses thereof |
| 06/27/2013 | WO2013021284A3 Anti-il-6 vaccine composition |
| 06/27/2013 | WO2012164380A3 Dispersion and detachment of cell aggregates |
| 06/27/2013 | WO2010077154A8 A method of producing a novel opioid peptide |
| 06/27/2013 | US20130165630 Aromatic compounds with sulfur containing ligands |
| 06/27/2013 | US20130165629 Bispecific t-cell activator antibody |
| 06/27/2013 | US20130165626 Antifreeze protein |
| 06/27/2013 | US20130165625 Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents |
| 06/27/2013 | US20130165624 Selective Binding Compounds |
| 06/27/2013 | US20130165388 Method of Producing a Paralytic Peptide |
| 06/27/2013 | US20130164317 Antimicrobial agent, bacterial strain, biosynthesis, and methods of use |
| 06/27/2013 | US20130164315 Vaccines - Screening Method |
| 06/27/2013 | US20130164254 Anticancer fusion protein |
| 06/27/2013 | US20130164237 Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them |
| 06/27/2013 | CA2856257A1 Process for the synthesis of therapeutic peptides |
| 06/26/2013 | EP2606903A1 Polypeptide inhibitors of HSP27 kinase and uses therefor |
| 06/26/2013 | EP2605786A2 Therapeutic peptides |
| 06/26/2013 | EP2311480B1 Compstatin analogs with improved activity |
| 06/26/2013 | CN103180336A Method for isolating cyclohexapeptide |
| 06/26/2013 | CN103180335A Process for the manufacture of degarelix and its intermediates |